Cumulative exposure to estrogen and psychosis: a peak bone mass, case-control study in first-episode psychosis

被引:25
|
作者
Maric, N
Popovic, V
Jasovic-Gasic, M
Pilipovic, N
van Os, J
机构
[1] Maastricht Univ, Dept Psychiat & Neuropsychol, S Limburg Mental Hlth Res & Teaching Network, European Grad Sch Neurosci, NL-6200 MD Maastricht, Netherlands
[2] Inst Psychiat, Div Psychol Med, London, England
[3] Univ Belgrade, Ctr Clin, Inst Rheumatol, YU-11000 Belgrade, Serbia Monteneg, Serbia
[4] Univ Belgrade, Ctr Clin, Inst Endocrinol, Neuroendocrine Unit, YU-11000 Belgrade, Serbia Monteneg, Serbia
[5] Univ Belgrade, Ctr Clin, Inst Psychiat, YU-11000 Belgrade, Serbia Monteneg, Serbia
关键词
schizophrenia; estrogen; sex differences; brain development;
D O I
10.1016/j.schres.2004.07.016
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The organizational structural effects of estrogen may be cumulative and permanent by impacting on neurodevelopment, giving rise to "neuroprotective" effects and eventually reduction of psychosis risk. Reduction in bone mineral density (BMD, in g/cm(2)), as a biological marker of reduced cumulative exposure to estrogen, may be a marker of increased psychosis risk. A sample of 19 first-episode female psychosis patients with minimal previous antipsychotic exposure (mean 10 weeks) and 20 female controls underwent advanced fan-beam dual X-ray absorptiometry (DXA) to assess lumbal spine BMD of the region of L1-L4. Mean BMD was around one standard deviation lower inpatients (1.13, S.D.=0.1.0) than in controls (1.25, S.D.-O.12;p=0.0021), and 84% of patients scored below the median value of the controls (OR=5.3, 95% CI: 1.2 24.2), The results are compatible with the hypothesis that psychosis in women may be associated causally with a reduced protective effect of estrogen over the course of development. (C) 2004 Elsevier B.V All rights reserved.
引用
收藏
页码:351 / 355
页数:5
相关论文
共 50 条
  • [1] Cumulative exposure to estrogen and psychosis: A peak bone mass, case-control study in first episode psychosis
    Maric, NP
    Popovic, V
    Gasic, MJ
    Pilipovic, N
    van Os, J
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 290 - 290
  • [2] Cumulative social disadvantage, ethnicity and first-episode psychosis: a case-control study
    Morgan, C.
    Kirkbride, J.
    Hutchinson, G.
    Craig, T.
    Morgan, K.
    Dazzan, P.
    Boydell, J.
    Doody, G. A.
    Jones, P. B.
    Murray, R. M.
    Leff, J.
    Fearon, P.
    PSYCHOLOGICAL MEDICINE, 2008, 38 (12) : 1701 - 1715
  • [3] Executive functions in first-episode psychosis: A case-control study
    Malta, SM
    Brucki, SM
    Chaves, AC
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 333 - 333
  • [4] Brain-relevant antibodies in first-episode psychosis: a matched case-control study
    Gaughran, Fiona
    Lally, John
    Beck, Katherine
    McCormack, Ruaidhri
    Gardner-Sood, Poonam
    Coutinho, Ester
    Jacobson, Leslie
    Lang, Bethan
    Sainz-Fuertes, Ricardo
    Papanastasiou, Evangelos
    Di Forti, Marta
    Nicholson, Tim
    Vincent, Angela
    Murray, Robin M.
    PSYCHOLOGICAL MEDICINE, 2018, 48 (08) : 1257 - 1263
  • [5] Reduced antioxidant defense in early onset first-episode psychosis: a case-control study
    Antonio Mico, Juan
    Olga Rojas-Corrales, Maria
    Gibert-Rahola, Juan
    Parellada, Mara
    Moreno, Dolores
    Fraguas, David
    Graell, Montserrat
    Gil, Javier
    Irazusta, Jon
    Castro-Fornieles, Josefina
    Soutullo, Cesar
    Arango, Celso
    Otero, Soraya
    Navarro, Ana
    Baeza, Inmaculada
    Martinez-Cengotitabengoa, Monica
    Gonzalez-Pinto, Ana
    BMC PSYCHIATRY, 2011, 11
  • [6] Reduced antioxidant defense in early onset first-episode psychosis: a case-control study
    Juan Antonio Micó
    Maria Olga Rojas-Corrales
    Juan Gibert-Rahola
    Mara Parellada
    Dolores Moreno
    David Fraguas
    Montserrat Graell
    Javier Gil
    Jon Irazusta
    Josefina Castro-Fornieles
    Cesar Soutullo
    Celso Arango
    Soraya Otero
    Ana Navarro
    Inmaculada Baeza
    Mónica Martínez-Cengotitabengoa
    Ana González-Pinto
    BMC Psychiatry, 11
  • [7] WHY DO FIRST-EPISODE PSYCHOSIS PATIENTS USE CANNABIS? CASE-CONTROL STUDY
    Gomez, L.
    Sabate, A.
    Mane, A.
    Berge, D.
    Merino, A.
    Bulbena, A.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [8] AUTOANTIBODIES IN FIRST EPISODE PSYCHOSIS: A MATCHED CASE-CONTROL STUDY
    Lally, John
    Gaughran, Fiona
    Beck, Katherine
    Nicholson, Tim
    McCormack, Ruaidhri
    Di Forti, Marta
    Murray, Robin
    Vincent, Angela
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S111 - S111
  • [9] A first episode psychosis case-control genetic association study
    Aitchison, Katherine
    Chow, P.
    Di Forti, M.
    Curtis, L.
    Arranz, M. J.
    Williamson, R. W.
    Gayzina, D.
    Cohen, S.
    Huezo-Diaz, P.
    Hoda, F.
    Butt, A.
    La Cascia, C.
    Miorelli, A.
    Mondelli, V.
    Navari, S.
    Eyeson, J.
    Clifford, D.
    Gafoor, R.
    Morgan, C.
    Papili, P.
    Ricciardi, A.
    Shaker, H.
    Saardzadeh-Sardahaee, F.
    Mantua, V.
    Fearon, P.
    Jones, P.
    Craig, I.
    Pariante, C.
    Dazzan, P.
    Powell, J.
    Collier, D. A.
    McGuffin, P.
    Murray, R. M.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2006, 141B (07) : 762 - 763
  • [10] Problem Gambling Associated with Aripiprazole: A Nested Case-Control Study in a First-Episode Psychosis Program
    Olivier Corbeil
    Stéphanie Corbeil
    Michel Dorval
    Pierre-Hugues Carmichael
    Isabelle Giroux
    Christian Jacques
    Marie-France Demers
    Marc-André Roy
    CNS Drugs, 2021, 35 : 461 - 468